2.Role of Endothelium-derived Relaxing and Hyperpolarizing Factors in the Relaxation of the Corpus Cavernosum.
Kwangsung PARK ; Eunyoung KIM ; Jongeun LEE ; Soobang RYU
Korean Journal of Urology 1995;36(3):241-246
It has been found that acetylcholine releases at least two different substances from the vascular endothelial cells, i.e., relaxing factor and hyperpolarizing factor. The present study was armed to investigate whether and to what extent these factors are involved in the relaxation of the corpus cavernosum. The corpus cavernosum was isolated from male New Zealand white rabbits and suspended longitudinally in an organ bath. The corporal strips were precontracted with phenylephrine, tetraethylammonium (TEA) or potassium chloride, and their responses to electrical field stimulation (EFS) or exogenously-administered acetylcholine were examined. EFS caused a frequency-dependent relaxation of the corpus cavernosum precontracted with phenylephrine, which was significantly inhibited or abolished in the presence of procaine (3.5 x 0.0001mol/L) or ouabain (0.0001mol/L). The corporal preparation precontracted with TEA also showed a frequency-dependent relaxation, however, the degree of which was lower than that precontracted with phenylephrine. EFS was without a significant effect on the corporal preparation precontracted with KCl (3 x 0.01mol/L). Acethylcholine elicted a concentration-dependent relaxation of the corpus cavernosum, the magnitude of which was significantly diminished in the presence of L-NAME (0.0001 mol/L). The relaxation response to EFS of the corporal preparation precontracted with phenylephrine was significantly attenuated in the presence of L-NAME (0.0001 mol/L), in which the residual relaxation was completely abolished by glibenclamide (0.00001mol/L). The relaxation of the corpus cavernosum in response to EFS was reversed into a contraction by methylene blue (0.0001mol/L) or TEA (0.01mol/L). These results suggest that endothelium-derived relaxing and hyperpolarizing factors released upon neural stimulation mediate the relaxation of the corpus cavernosum. It is also suggested that EDRF activates soluble guanylate cyclase and EDHF does ATP-sensitive potassium channels.
Acetylcholine
;
Arm
;
Baths
;
Endothelial Cells
;
Glyburide
;
Guanylate Cyclase
;
Humans
;
KATP Channels
;
Male
;
Methylene Blue
;
NG-Nitroarginine Methyl Ester
;
Ouabain
;
Phenylephrine
;
Potassium Chloride
;
Procaine
;
Rabbits
;
Relaxation*
;
Tea
;
Tetraethylammonium
3.Enhancement of N-methyl-D-aspartateNMDA Receptor 2B-mediated Neurotoxi-city after Hypoxia in the Rat Hippocampal Formation.
Yong Wook JUNG ; So Hee HAM ; Il Soo MOON ; Bok Hyun KO
Korean Journal of Anatomy 1997;30(4):361-374
Ischemic brain hippocampal formation has been developed to understand the relationship between delayed neuronal damage and the expression of NMDA receptor subunits[NR2A, NR2B], MAP2, and NF200 in ttle conditions of hypoxia. Changes of NR subunits[NR2A, 2B], MAP2 6nd NF200 in rat brain postsynaptic density[PSD] after hypoxic injury were investigated through immunoblot analyses. To understand the effect of Ca2+ influx through NMDA receptors on neuronal damage which is manifested by morphological change, cytoskeletal disruption was examined through H & E, toluidine blue and immunohistochemical studies. The expression of NR2B was increased than normal at 30 hours after hypoxia. At this time, the expression of MAP2 and NF200 was markedly decreased and their morphology was more eosinophilic than normal and then became darker with expanded perineuronal space. Irreversible neuronal cell damage in hypoxic hippocampal formation is most prominent in CA3 region of hippocampus and the process is triggered by Ca2+ influx through NR1/MR2B receptor channel at 30 hour after initial hypoxic insult. Ca2+ influx through NR1/MR2B receptor channel may activate intracellular proteases which would degrade cytoskeleton. Proteolysis of cytoskeleton leads to its reorganization and eventually damages normal function of cell membrane which causes neuronal cell death. And, morphological changes of neuronal cells in hypoxic conditions were manifested as red neurons in the stage of reactive change, and as dark neuron in the stage of late hypoxic cell damage.
Animals
;
Anoxia*
;
Brain
;
Cell Death
;
Cell Membrane
;
Cytoskeleton
;
Eosinophils
;
Hippocampus*
;
N-Methylaspartate
;
Neurons
;
Peptide Hydrolases
;
Proteolysis
;
Rats*
;
Receptors, N-Methyl-D-Aspartate
;
Tolonium Chloride
4.Attenuation of Vasoconstriction by Estrogen Through Endothelium -Independent Mechanism in Human Uterine Artery.
Byeong Jun JUNG ; Hyoung Moo PARK ; Min HUR ; Moo Yeool LEE
Korean Journal of Obstetrics and Gynecology 1999;42(8):1733-1743
OBJECTIVE: This study was performed to investigate whether 1) estrogen induces the change of vascular tone in endothelium-denuded human uterine artery, and 2) endothelium-independent vascular reactivity may be mediated by intracellular calcium ion modulation. METHODS: The uterine arteries from 34 premenopausal women were obtained at the time of hysterectomy due to various indications and endothelium was denuded. Vascular reactivity was monitored by using Isometric force transducer and recorded by physiograph. Endothelial integrity was assessed by sequential administration of 1micrometer norepinephrine(alpha-adrenergic stimulant) and 10 micrometer acetylcholine (endothelium -dependent vasorelaxant). Integrity of smooth muscle was measured by administration of 10 micrometer sodium nitroprusside (endothelium - independent vasorelaxant) and 10 micrometer tamsulosin(alpha-adrenergic blocker). A dose-dependent action of estrogen was measured on denuded uterine arteries, pretreated with norepinephrine and potassium chloride. In media contained denuded uterine arteries pretreated with 70mM potassium chloride and estradiol(3X10-5M), nitric oxide and its inhibitor, N-nitro-L-arginine methyl ester(L-NAME) was administered, respectively, in order to verify the vasodilation effect. Statistical tests were performed at the 5% level of significance using the SPSS PC+ package. RESULTS: Acethylcholine has little effect but sodium nitroprusside & talmsulosin showed marked relaxation, which suggested loss of endothelial function and adequacy of smooth muscle function. The contraction by norephinephrine(1 M) revealed estrogen induced relaxation which was concentration-dependent from 3 10-8M to 3 10-5M in concentration of 17 -estradiol. The contraction by high potassium solution 70mM was also inhibited by estrogen in concentration-dependent manner. This vasorelaxant effect of estrogen on endothelium-denuded uterine artery was not affected by addition of nitric oxide(NO) precursor, L-arginine and nitric oxide synthase(NOS) inhibitor, L-NAME. CONCLUSION: The results of this study revealed that estrogen has vasorelaxant effect on endothelium endothelium-denuded uterine artery by calcium antagonistic property through direct inhibitory effect on receptor- and voltage dependent calcium ion channels of smooth muscles. This vasorelaxant effect of estrogen on endothelium-denuded uterine artery was NO independent.
Acetylcholine
;
Arginine
;
Calcium
;
Calcium Channels
;
Endothelium*
;
Estrogens*
;
Female
;
Humans*
;
Hysterectomy
;
Muscle, Smooth
;
NG-Nitroarginine Methyl Ester
;
Nitric Oxide
;
Nitroprusside
;
Norepinephrine
;
Potassium
;
Potassium Chloride
;
Relaxation
;
Transducers
;
Uterine Artery*
;
Vasoconstriction*
;
Vasodilation
5.Contractile and Inhibitory Effects of McN-A-343 and Acetylcholine on Isolated Arteries.
Gi Joong JUNG ; Sam Suk KANG ; Je Hyuk LEE ; Young Hong BAIK
Journal of Korean Neurosurgical Society 1990;19(3):406-412
Effect of acetylcholine(ACh) and McN-A-343 on porcine coronary artery and rabbit thoracic aorta were investigated in isolated preparations with or without intact endothelium. In the porcine coronary artery, ACh produced concentration dependent contraction which was greater in rings without the endothelium than in intact endothelial rings, but McN-A-343 did not alter the basel tension in both tissues. ACh relaxed contraction induced by 5-hydroxytryptamine(5-HT) in only intact endothelial rings, while NcN-A-343 inhibited the 5-HT induced tension in both preparations dose dependently. Carbachol elicited a prominent contraction in both tissues. The carbacol-induced tension was markedly inhibited by McN-A-343 in either rings with or without endothelium, while ACh contracted further the tension. ACh and McN-A-343 did not after the KCi induced tension, but clearly potentiated the contraction induced by Bay K 8644 in intact endothelial rings. In rabbit thoracic aorta, ACh elicited contraction in a concentration-dependent fashion which was potentiated by removal of endothelium, but McN-A-343 did not affect the basal tension of both rings. ACh inhibited the 5-HT-induced contraction in only intact endothelial ring, but McN-A-343 did not change the contraction of both rings. Conclusively, ACh produces endothelium-dependent relaxation in both arteries, while McN-A-343 elevated endothelium-independent inhibition to 5-HT or carbachol-induced tension.
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride*
;
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
;
Acetylcholine*
;
Aorta, Thoracic
;
Arteries*
;
Carbachol
;
Coronary Vessels
;
Endothelium
;
Relaxation
;
Serotonin
6.Colonic Transit Disorder Mediated by Downregulation of Interstitial Cells of Cajal/Anoctamin-1 in Dextran Sodium Sulfate-induced Colitis Mice
Chen LU ; Hongli LU ; Xu HUANG ; Shaohua LIU ; Jingyu ZANG ; Yujia LI ; Jie CHEN ; Wenxie XU
Journal of Neurogastroenterology and Motility 2019;25(2):316-331
BACKGROUND/AIMS: Interstitial cells of Cajal (ICC) and their special calcium-activated chloride channel, anoctamin-1 (ANO1) play pivotal roles in regulating colonic transit. This study is designed to investigate the role of ICC and the ANO1 channel in colonic transit disorder in dextran sodium sulfate (DSS)-treated colitis mice. METHODS: Colonic transit experiment, colonic migrating motor complexes (CMMCs), smooth muscle spontaneous contractile experiments, intracellular electrical recordings, western blotting analysis, and quantitative polymerase chain reaction were applied in this study. RESULTS: The mRNA and protein expressions of c-KIT and ANO1 channels were significantly decreased in the colons of DSS-colitis mice. The colonic artificial fecal-pellet transit experiment in vitro was significantly delayed in DSS-colitis mice. The CMMCs and smooth muscle spontaneous contractions were significantly decreased by 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), an ANO1 channel blocker, and NG-Nitro-L-arginine methyl ester hydrochloride (L-NAME), an inhibitor of nitric oxide synthase activity, in DSS-colitis mice compared with that of control mice. Intracellular electrical recordings showed that the amplitude of NPPB-induced hyperpolarization was more positive in DSS-colitis mice. The electric field stimulation-elicited nitric-dependent slow inhibitory junctional potentials were also more positive in DSS-colitis mice than those of control mice. CONCLUSION: The results suggest that colonic transit disorder is mediated via downregulation of the nitric oxide/ICC/ANO1 signalling pathway in DSS-colitis mice.
Animals
;
Blotting, Western
;
Chloride Channels
;
Colitis
;
Colon
;
Dextrans
;
Down-Regulation
;
In Vitro Techniques
;
Interstitial Cells of Cajal
;
Mice
;
Muscle, Smooth
;
Myoelectric Complex, Migrating
;
NG-Nitroarginine Methyl Ester
;
Nitric Oxide Synthase
;
Polymerase Chain Reaction
;
RNA, Messenger
;
Sodium
7.R-(-)-TNPA, a Dopaminergic D2 Receptor Agonist, Inhibits Catecholamine Release from the Rat Adrenal Medulla.
Soon Pyo HONG ; Hong Joo SEO ; Dong Yoon LIM
The Korean Journal of Physiology and Pharmacology 2006;10(5):273-282
The aim of the present study was to investigate the effects of R-(-)-2,10,11-trihydroxy-N-propylnoraporphine [R-(-)-TNPA], a selective agonist of dopaminergic D2 receptor and S(-)-raclopride, a selective antagonist of dopaminergic D2 receptor, on the secretion of catecholamines (CA) evoked by cholinergic stimulation and membrane-depolarization in the isolated perfused model of the rat adrenal gland, and also to establish its mechanism of action. R-(-)-TNPA (10~100 micrometer) perfused into an adrenal vein for 60 min produced dose- and time-dependent inhibition in CA secretory responses evoked by ACh (5.32 mM), high K+ (56 mM), DMPP (100 micrometer) and McN-A-343 (100 micrometer). R-(-)-TNPA itself did also fail to affect basal CA output. Also, in adrenal glands loaded with R-(-)-TNPA (30 micrometer), the CA secretory responses evoked by Bay-K-8644 (10 micrometer), an activator of L-type Ca2+ channels and cyclopiazonic acid (10 micrometer), an inhibitor of cytoplasmic Ca2+-ATPase were also inhibited. However, S(-)-raclopride (1~10 micrometer), given into an adrenal vein for 60 min, enhanced the CA secretory responses evoked by ACh, high K+, DMPP and McN-A-343 only for the first period (4 min), although it alone has weak effect on CA secretion. Moreover, S(-)-raclopride (3.0 micrometer) in to an adrenal vein for 60 min also augmented the CA release evoked by BAY-K-8644 and cyclopiazonic acid only for the first period (4 min). However, after simultaneous perfusion of R-(-)-TNPA (30 micrometer) and S(-)-raclopride (3.0 micrometer), the inhibitory responses of R-(-)-TNPA (30 micrometer) on the CA secretion evoked by ACh, high K+, DMPP, McN-A-343, Bay-K-8644, and cyclopiazonic acid were significantly reduced. Taken together, these experimental results suggest that R-(-)-TNPA greatly inhibits the CA secretion from the perfused rat adrenal medulla evoked by cholinergic stimulation (both nicotininc and muscarinic receptors) and membrane depolarization, but S(-)-raclopride rather enhances the CA release by them. It seems that this inhibitory of R-(-)-TNPA may be mediated by stimulation of inhibitory dopaminergic D2 receptors located on the rat adrenomedullary chromaffin cells, while the facilitatory effect of S(-)-raclopride is due to the blockade of dopaminergic D2 receptors, which are relevant to extra- and intracellular calcium mobilization. Therefore, it is thought that dopaminergic D2 receptors may be involved in regulation of CA release in the rat adrenal medulla.
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
;
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
;
Adrenal Glands
;
Adrenal Medulla*
;
Animals
;
Calcium
;
Catecholamines
;
Chromaffin Cells
;
Cytoplasm
;
Dimethylphenylpiperazinium Iodide
;
Membranes
;
Perfusion
;
Rats*
;
Veins
8.Roles of Dopaminergic D1 and D2 Receptors in Catecholamine Release from the Rat Adrenal Medulla.
Young Joo BAEK ; Yoo Seong SEO ; Dong Yoon LIM
The Korean Journal of Physiology and Pharmacology 2008;12(1):13-23
The aim of the present study was designed to establish comparatively the inhibitory effects of D1-like and D2-like dopaminergic receptor agonists, SKF81297 and R(-)-TNPA on the release of catecholamines (CA) evoked by cholinergic stimulation and membrane depolarization from the isolated perfused model of the rat adrenal medulla. SKF81297 (30 micrometer) and R-(-)-TNPA (30 micrometer) perfused into an adrenal vein for 60 min, produced great inhibition in the CA secretory responses evoked by ACh (5.32x10(-3) M), DMPP (10(-4) M), McN-A-343 (10(-4) M), high K+ (5.6x10(-2) M), Bay-K-8644 (10 micrometer), and cyclopiazonic acid (10 micrometer), respectively. For the release of CA evoked by ACh, high K+, DMPP, McN-A-343, Bay-K-8644 and cyclopiazonic acid, the following rank order of inhibitory potency was obtained: SKF81297>R-(-)-TNPA. However, R(+)-SCH23390, a selectve D1-like dopaminergic receptor antagonist, and S(-)-raclopride, a selectve D2-like dopaminergic receptor antagonist, enhanced the CA secretory responses evoked by ACh, high K+, DMPP, McN-A-343, Bay-K-8644 and cyclopiazonic acid only for 0~4 min. The rank order for the enhancement of CA release evoked by high K+, McN-A-343 and cyclopiazonic acid was R(+)-SCH23390>S(-)-raclopride. Also, the rank order for ACh, DMPP and Bay-K-8644 was S(-)-raclopride > R(+)-SCH23390. Taken together, these results demonstrate that both SKF81297 and R-(-)-TNPA inhibit the CA release evoked by stimulation of cholinergic (both nicotinic and muscarinic) receptors and the membrane depolarization from the isolated perfused rat adrenal gland without affecting the basal release, respectively, but both R(+)-SCH23390 and S(-)-raclopride facilitate the CA release evoked by them. It seems likely that the inhibitory effects of SKF81297 and R-(-)-TNPA are mediated by the activation of D1-like and D2-like dopaminergic receptors located on the rat adrenomedullary chromaffin cells, respectively, whereas the facilitatory effects of R(+)-SCH23390 and S(-)-raclopride are mediated by the blockade of D1-like and D2-like dopaminergic receptors, respectively: this action is possibly associated with extra- and intracellular calcium mobilization. Based on these results, it is thought that the presence of dopaminergic D1 receptors may play an important role in regulation of the rat adrenomedullary CA secretion, in addition to well-known dopaminergic D2 receptors.
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
;
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
;
Adrenal Glands
;
Adrenal Medulla
;
Animals
;
Benzazepines
;
Calcium
;
Catecholamines
;
Chromaffin Cells
;
Dimethylphenylpiperazinium Iodide
;
Indoles
;
Membranes
;
Rats
;
Veins
9.Influence of SKF81297 on Catecholamine Release from the Perfused Rat Adrenal Medulla.
Deok Ho CHOI ; Jong Hee CHA ; Dong Yoon LIM
The Korean Journal of Physiology and Pharmacology 2007;11(5):197-206
The aim of the present study was to investigate the effects of 6-chloro-7,8-dihydroxy-1-phenyl-2,3, 4,5-tetrahydro-1H-3-benzazepine (SKF81297), a selective agonist of dopaminergic D1 receptor, on the secretion of catecholamines (CA) evoked by cholinergic stimulation and membrane-depolarization in the isolated perfused rat adrenal gland, and also to elucidate the mechanism involved. SKF81297 (10~100microM) perfused into an adrenal vein for 60 min produced dose- and time-dependent inhibition of CA secretory responses evoked by ACh (5.32 mM), high K+ (56 mM), DMPP (100microM) and McN-A-343 (100microM). Also, in adrenal glands loaded with SKF81297 (30microM), the CA secretory responses evoked by Bay-K-8644 (10microM), an activator of L-type Ca2+ channels and cyclopiazonic acid (10microM), an inhibitor of cytoplasmic Ca2+-ATPase were also inhibited. However, in the presence of the dopamine D1 receptor antagonist, (R)-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-benzazepine-7-ol (SCH23390, 3microM), which is a selective antagonist of dopaminergic D1 receptor, the inhibitory responses of SKF81297 (30microM) on the CA secretion evoked by ACh, high K+, DMPP, McN-A-343, Bay-K-8644, and cyclopiazonic acid were significantly reduced. Collectively, these experimental results suggest that SKF81297 inhibits the CA secretion from the rat adrenal medulla evoked by cholinergic stimulation (both nicotininc and muscarinic receptors) and membrane depolarization. This inhibitory of SKF81297 seems to be mediated by stimulation of dopaminergic D1 receptors located on the rat adrenomedullary chromaffin cells, which are relevant to extra- and intracellular calcium mobilization. Therefore, it is thought that the presence of the dopaminergic D1 receptors may be involved in regulation of CA release in the rat adrenal medulla.
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
;
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
;
Adrenal Glands
;
Adrenal Medulla*
;
Animals
;
Calcium
;
Catecholamines
;
Chromaffin Cells
;
Cytoplasm
;
Dimethylphenylpiperazinium Iodide
;
Membranes
;
Rats*
;
Receptors, Dopamine D1
;
Veins
10.Effect of Doxorubicin on Catecholamine Release in the Isolated Perfused Rat Adrenal Gland.
Dong Yoon LIM ; Song Hoon OH ; Yoo Seung SEOH ; Eun Sook LEE ; Il Hwan KIM ; Seong Ho JO ; Soon Pyo HONG
The Korean Journal of Physiology and Pharmacology 2002;6(4):215-224
The present study was undertaken to investigate the effect of doxorubicin (DX) on secretion of catecholamines (CA) evoked by ACh, high K+, DMPP and McN-A-343 from the isolated perfused rat adrenal gland and to establish the mechanism of its action. DX (10(-7)~10(-6) M) perfused into an adrenal vein for 60 min produced relatively dose- and time-dependent inhibition of CA secretory responses evoked by ACh (5.32 X 10(-3) M), DMPP (10(-4) M) and McN-A-343 (10(-4) M). However, lower dose of DX did not affect CA secretion by high K+ (5.6 X 10(-2) M), but its higher doses depressed time-dependently CA secretion evoked by high K+. DX itself did also fail to affect basal CA output. In adrenal glands loaded with DX (3 X 10(-7) M), CA secretory responses evoked by Bay-K-8644, an activator of L-type Ca2+ channels and cyclopiazonic acid, an inhibitor of cytoplasmic Ca2+-ATPase were time-dependently inhibited. Furthermore, daunorubicin (3 X 10(-7) M), given into the adrenal gland for 60 min, attenuated CA secretory responses evoked by ACh, high K+, DMPP and McN-A-343. Taken together, these results suggest that DX causes relatively dose- and time-dependent inhibition of CA secretory responses evoked by stimulation of cholinergic (both nicotinic and muscarinic) receptors from the isolated perfused rat adrenal gland. However, lower dose of DX did not affect CA secretion by high K+, and higher doses of DX reduced time-dependently CA secretion of high K+. It is thought that these effects of DX may be mediated by inhibiting both influx of extracellular calcium into the rat adrenomedullary chromaffin cells and intracelluar calcium release from the cytoplasmic store. Also, there was no difference in the mode of action between DX and daunorubicin in rat adrenomedullary CA secretion.
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
;
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
;
Adrenal Glands*
;
Animals
;
Calcium
;
Catecholamines
;
Chromaffin Cells
;
Cytoplasm
;
Daunorubicin
;
Dimethylphenylpiperazinium Iodide
;
Doxorubicin*
;
Rats*
;
Veins